United Kingdom · Delayed Price · Currency is GBP · Price in GBX Genus Statistics
Total Valuation
Genus has a market cap or net worth of GBP 1.48 billion. The enterprise value is 1.55 billion.
| Market Cap | 1.48B |
| Enterprise Value | 1.55B |
Important Dates
The next confirmed earnings date is Thursday, February 25, 2027.
| Earnings Date | Feb 25, 2027 |
| Ex-Dividend Date | Nov 12, 2026 |
Share Statistics
Genus has 66.11 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | 66.11M |
| Shares Outstanding | 66.11M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 78.33% |
| Float | 61.73M |
Valuation Ratios
The trailing PE ratio is 5.28 and the forward PE ratio is 21.38. Genus's PEG ratio is 1.59.
| PE Ratio | 5.28 |
| Forward PE | 21.38 |
| PS Ratio | 2.25 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | 23.97 |
| P/OCF Ratio | 19.94 |
| PEG Ratio | 1.59 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.33, with an EV/FCF ratio of 25.00.
| EV / Earnings | 5.42 |
| EV / Sales | 2.35 |
| EV / EBITDA | 10.33 |
| EV / EBIT | 13.61 |
| EV / FCF | 25.00 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.22 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.93 |
| Debt / FCF | 1.74 |
| Interest Coverage | 4.91 |
Financial Efficiency
Return on equity (ROE) is 45.88% and return on invested capital (ROIC) is 8.75%.
| Return on Equity (ROE) | 45.88% |
| Return on Assets (ROA) | 5.15% |
| Return on Invested Capital (ROIC) | 8.75% |
| Return on Capital Employed (ROCE) | 8.77% |
| Weighted Average Cost of Capital (WACC) | 9.54% |
| Revenue Per Employee | 225,300 |
| Profits Per Employee | 97,672 |
| Employee Count | 2,921 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 4.54 |
Taxes
In the past 12 months, Genus has paid 25.00 million in taxes.
| Income Tax | 25.00M |
| Effective Tax Rate | 8.06% |
Stock Price Statistics
The stock price has decreased by -14.84% in the last 52 weeks. The beta is 0.91, so Genus's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -14.84% |
| 50-Day Moving Average | 2,225.48 |
| 200-Day Moving Average | 2,432.00 |
| Relative Strength Index (RSI) | 52.09 |
| Average Volume (20 Days) | 229,318 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genus had revenue of GBP 658.10 million and earned 285.30 million in profits. Earnings per share was 4.25.
| Revenue | 658.10M |
| Gross Profit | 284.10M |
| Operating Income | 79.00M |
| Pretax Income | 310.10M |
| Net Income | 285.30M |
| EBITDA | 102.60M |
| EBIT | 79.00M |
| Earnings Per Share (EPS) | 4.25 |
Balance Sheet
The company has 43.70 million in cash and 107.50 million in debt, with a net cash position of -63.80 million or -0.97 per share.
| Cash & Cash Equivalents | 43.70M |
| Total Debt | 107.50M |
| Net Cash | -63.80M |
| Net Cash Per Share | -0.97 |
| Equity (Book Value) | 766.70M |
| Book Value Per Share | 11.60 |
| Working Capital | 142.40M |
Cash Flow
In the last 12 months, operating cash flow was 74.40 million and capital expenditures -12.50 million, giving a free cash flow of 61.90 million.
| Operating Cash Flow | 74.40M |
| Capital Expenditures | -12.50M |
| Depreciation & Amortization | 23.60M |
| Net Borrowing | -153.20M |
| Free Cash Flow | 61.90M |
| FCF Per Share | 0.94 |
Margins
Gross margin is 43.17%, with operating and profit margins of 12.00% and 43.35%.
| Gross Margin | 43.17% |
| Operating Margin | 12.00% |
| Pretax Margin | 47.12% |
| Profit Margin | 43.35% |
| EBITDA Margin | 15.59% |
| EBIT Margin | 12.00% |
| FCF Margin | 9.41% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 1.57%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 1.57% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.61% |
| FCF Payout Ratio | 37.59% |
| Buyback Yield | -0.41% |
| Shareholder Yield | 1.16% |
| Earnings Yield | 18.94% |
| FCF Yield | 4.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Genus is 3,039.85, which is 35.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 3,039.85 |
| Price Target Difference | 35.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 2.16% |
| EPS Growth Forecast (3Y) | 5.21% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Genus has an Altman Z-Score of 5.92 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.92 |
| Piotroski F-Score | 6 |